A Phase I Study of SAHA and Temozolomide in Children With Relapsed or Refractory Primary Brain or Spinal Cord Tumors.
Phase of Trial: Phase I
Latest Information Update: 01 May 2013
At a glance
- Drugs Temozolomide (Primary) ; Vorinostat (Primary)
- Indications Brain cancer; CNS cancer; Glioma
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- 31 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2012 Planned end date changed from 1 Jan 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 14 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.